Skip to main content
SpringerLink
Log in

Ferritin and Desferrioxamine Attenuate Xanthine Oxidase-Dependent Leak in Isolated Perfused Rat Lungs

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Iron, through its participation in reactions that generate reactive oxygen species, may contribute to the oxidative lung injury observed in patients with acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS). A number of investigators have shown that the endogenous iron storage protein ferritin increases in the blood of patients with and at-risk for ALI and ARDS, but the significance of these increases are not known. In the present investigation, we measured lung tissue levels of thiobarbituric acid reactive substances (TBARS) and lung leak in isolated rat lungs perfused with xanthine oxidase (XO) and purine, an enzymatic system which generates reactive oxygen species. We found that adding ferritin (100 ng/mL) or desferrioxamine (DFO, 10 mM), an iron chelator, to the vascular perfusate solution decreased oxidant-induced leak in isolated rat lungs perfused with XO and purine. Addition of ferritin or DFO also decreased TBARS in isolated rat lungs perfused with XO and purine; neither ferritin nor DFO, however, decreased XO activity in vitro. Our results suggest that oxidative lung leak may be altered by the availability of reactive iron and that ferritin may contribute to protection against oxidative lung injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Chabot, F., J. A. Mitchell, J. M. C. Gutteridge, and T. W. Evans. 1998. Reactive oxygen species in acute lung injury. Eur. Respir. J. 11:745–757.

    Google Scholar 

  2. Repine, J. E. 1992. Scientific perspectives on adult respiratory distress syndrome. Lancet. 339:466–469.

    Google Scholar 

  3. Cochrane, C. G., R. G. Spragg, and S. D. Revak. 1983. Pathogenesis of the adult respiratory distress syndrome: evidence of oxidant activity in bronchoalveolar lavage fluid. J. Clin. Invest. 71:754–758.

    Google Scholar 

  4. Louie, S., B. Halliwell, and C. E. Cross. 1997. Adult respiratory distress syndrome: a radical perspective. Adv. Pharmacol. 38:457–490.

    Google Scholar 

  5. Richard, C., F. Lemonnier, M. Thibault, M. Couturier, and P. Auzepy. 1990. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit. Care Med. 18:4–9.

    Google Scholar 

  6. Quinlan, G. J., N. J. Lamb, T. W. Evans, and J. M. Gutteridge. 1996. Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit. Care Med. 24:241–246.

    Google Scholar 

  7. Baldwin, S. R., C. M. Grum, L. A. Boxer, R. H. Simon, L. H. Ketai, and D. J. Devall. 1986. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet. 1:11–14.

    Google Scholar 

  8. Kietzmann, D., R. Kahl, M. Muller, H. Burchardi, and D. Kettler. 1993. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS.Int. Care Med. 19:78–81.

    Google Scholar 

  9. Quinlan, G. J., T. W. Evans, and J. M. Gutteridge. 1994. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic. Res. 20:289–298.

    Google Scholar 

  10. Seeger, W., F. Grimminger, M. Barden, G. Becker, J. Lohmeyer, D. Heinrich, and H. G. Lasch. 1991. Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with noncardiogenic pulmonary edema, but not in those with cardiogenic edema. Int. Care Med. 17:1–6.

    Google Scholar 

  11. Bertrand, Y., J. Pincemail, G. Hanique, B. Denis, L. Leenaerts, L. Vankeerberghen, and C. Deby. 1989. Differences in tocopherollipid ratios in ARDS and non-ARDS patients. Int. Care Med. 15:87–93.

    Google Scholar 

  12. Pacht, E. R., A. P. Timerman, M. G. Lykens, and A. J. Merola. 1991. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest. 100:1397–1403.

    Google Scholar 

  13. Balla, G., H. S. Jacob, J. Balla, M. Rosenberg, K. Nath, F. Apple, J. W. Eaton, and G. M. Vercellotti. 1992. Ferritin: a cytoprotective antioxidant strategem of endothelium.J. Biol. Chem. 267:18148–18153.

    Google Scholar 

  14. Biemond, P., H. G. van Eijk, A. J. Swaak, and J. F. Koster. 1984. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J. Clin. Invest. 73:1576–1579.

    Google Scholar 

  15. Biemond, P., A. J. Swaak, H. G. van Eijk, and J. F. Koster. 1988.Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic. Biol. Med. 4:185–198.

    Google Scholar 

  16. Morris, C. J., J. R. Earl, C. W. Trenam, and D. R. Blake. 1995.Reactive oxygen species and iron-a dangerous partnership in inflammation. Int. J. Biochem. Cell Biol. 27:109–122.

    Google Scholar 

  17. Herbert, V., S. Shaw, E. Jayatilleke, and T. Stopler-Kasdan. 1994.Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin.Stem. Cells (Dayt.) 12:289–303.

    Google Scholar 

  18. Connelly, K. G., and J. E. Repine. 1997. Markers for predicting the development of acute respiratory distress syndrome. Annu. Rev.Med. 48:429–445.

    Google Scholar 

  19. Connelly, K. G., M. Moss, P. E. Parsons, E. E. Moore, F. A. Moore, P. C. Giclas, P. A. Seligman, and J. E. Repine. 1997. Serum ferritin as a predictor of the acute respiratory distress syndrome.Am. J. Respir. Crit. Care Med. 155:21–25.

    Google Scholar 

  20. Sharkey, R. A., S. C. Donnelly, K. G. Connelly, C. E. Robertson, C. Haslett, and J. E. Repine. 1999. Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome.Am. J. Respir. Crit. Care Med. 159:1506–1509.

    Google Scholar 

  21. Johnson, K. J., P. A. Ward, R. G. Kunkel, and B. S. Wilson. 1986. Mediation of IgA induced lung injury in the rat.Role of macrophages and reactive oxygen products. Lab. Invest. 54:499–506.

    Google Scholar 

  22. Okayama, N., M. B. Grisham, C. G. Kevil, L. A. Eppihimer, D.A. Wink, and J. S. Alexander. 1999. Effect of reactive oxygen metabolites on endothelial permeability: role of nitric oxide and iron. Microcirculation. 6:107–116.

    Google Scholar 

  23. Fridovich, I. 1970. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase.J. Biol. Chem. 245:4053–4057.

    Google Scholar 

  24. Hybertson, B. M., R. P. Kitlowski, E. K. Jepson, and J. E. Repine. 1998. Supercritical fluid-aerosolized vitamin E pretreatment decreases leak in isolated oxidant-perfused rat lungs.J. Appl. Physiol. 84:263–268.

    Google Scholar 

  25. Terada, L. S., J. J. Dormish, P. F. Shanley, J. A. Leff, B. O. Anderson, and J. E. Repine. 1992. Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion.Am. J. Physiol. 263:L394–L401.

    Google Scholar 

  26. Yokoyama, Y., J. S. Beckman, T. K. Beckman, J. K. Wheat, T. G. Cash, B. A. Freeman, and D. A. Parks. 1990. Circulating xanthine oxidase: potential mediator of ischemic injury. Am. J. Physiol. 258:G564–G570.

    Google Scholar 

  27. Fox, R. B., R. B. Parad, R. H. Demling, and M. Merrigan. 1986.Permeability of isolated rat lungs perfused with purine and xanthine oxidase under constant perfusing pressure. In: Physiology of Oxygen Radicals, A. E. Taylor, S. Matalon and P. Ward, eds: American Physiological Society, Bethesda, MD, p. 163–168.

    Google Scholar 

  28. Weinbroum, A., V. G. Nielsen, S. Tan, S. Gelman, S. Matalon, K.A. Skinner, E. Bradley, Jr., and D. A. Parks. 1995. Liver ischemiareperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase.Am. J. Physiol. 268:G988–G996.

    Google Scholar 

  29. Grum, C. M., R. A. Ragsdale, L. H. Ketai, and R. H. Simon. 1987.Plasma xanthine oxidase activity in patients with ARDS. J. Crit. Care. 2:22–26.

    Google Scholar 

  30. Friedl, H. P., D. J. Smith, G. O. Till, P. D. Thomson, D. S. Louis, and P. A. Ward. 1990. Ischemia-reperfusion in humans: appearance of xanthine oxidase activity. Am. J. Pathol. 136:491–495.

    Google Scholar 

  31. Tan, S., S. Gelman, J. K. Wheat, and D. A. Parks. 1995. Circulating xanthine oxidase in human ischemia reperfusion. South Med. J. 88:479–482.

    Google Scholar 

  32. Morse, E. 1947. Anthrone in estimating low concentrations of sucrose. Anal. Chem. 19:1012–1013.

    Google Scholar 

  33. Rinaldo, J. E., and M. Gorry. 1990. Protection by deferoxamine from endothelial injury: a possible link with inhibition of intracellular xanthine oxidase. Am. J. Respir. Cell Mol. Biol. 3:525–533.

    Google Scholar 

  34. Cozzi, A., P. Santambrogio, S. Levi, and P. Arosio. 1990. Iron detoxifying activity of ferritin. Effects of H and L human apoferritins on lipid peroxidation in vitro. FEBS Lett. 277:119–122.

    Google Scholar 

  35. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351–358.

    Google Scholar 

  36. Quinlan, G. J., N. J. Lamb, R. Tilley, T. W. Evans, and J. M. C. Gutteridge. 1997. Plasma hypoxanthine levels in ARDS: Implications for oxidative stress, morbidity, and mortality.Am. J. Respir.Crit. Care Med. 155:479–484.

    Google Scholar 

  37. Kavanagh, B. P., A. Mouchawar, J. Goldsmith, and R. G. Pearl. 1994. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J. Appl. Physiol. 76:1324–1329.

    Google Scholar 

  38. Berisha, H., H. Foda, H. Sakakibara, M. Trotz, H. Pakbaz, and S. I. Said. 1990. Vasoactive intestinal peptide prevents lung injury due to xanthine /xanthine oxidase. Am. J. Physiol. 259:L151–L155.

    Google Scholar 

  39. Seibert, A. F., A. E. Taylor, J. B. Bass, and J. Haynes, Jr. 1991.Hemoglobin potentiates oxidant injury in isolated rat lungs. Am.J. Physiol. 260:H1980–H1984.

    Google Scholar 

  40. Sullivan, J. L., G. O. Till, P. A. Ward, and R. B. Newton. 1989.Nutritional iron restriction diminishes acute complement-dependent lung injury. Nutr. Res. 9:625–634.

    Google Scholar 

  41. Sappey, C., J. R. Boelaert, S. Legrand-Poels, C. Forceille, A. Favier, and J. Piette. 1995. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res. Hum. Retroviruses 11:1049–1061.

    Google Scholar 

  42. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P.A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181–1194.

    Google Scholar 

  43. Lin, M., R. A. Rippe, O. Niemela, G. Brittenham, and H. Tsukamoto. 1997. Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages.Am. J. Physiol. 272:G1355–G1364.

    Google Scholar 

  44. Sullivan, J. L. 1981. Iron and the sex difference in heart disease risk. Lancet. June 13:1293–1294.

    Google Scholar 

  45. Gutteridge, J. M., G. J. Quinlan, S. Mumby, A. Heath, and T.W. Evans. 1994. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, ironbinding, and free radical-scavenging proteins. J. Lab. Clin. Med. 124:263–273.

    Google Scholar 

  46. Marx, J. J., and B. S. van Asbeck. 1996. Use of iron chelators in preventing hydroxyl radical damage: adult respiratory distress syndrome as an experimental model for the pathophysiology and treatment of oxygen-radical-mediated tissue damage. Acta. Haematol. 95:49–62.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Webb-Waring Institute for Cancer, Aging, and Antioxidant Research, University of Colorado Health Sciences Center, Denver, CO, 80262

    Brooks M. Hybertson, Kevin G. Connelly, Raquel T. Buser & John E. Repine

Authors
  1. Brooks M. Hybertson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin G. Connelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raquel T. Buser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John E. Repine
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hybertson, B.M., Connelly, K.G., Buser, R.T. et al. Ferritin and Desferrioxamine Attenuate Xanthine Oxidase-Dependent Leak in Isolated Perfused Rat Lungs. Inflammation 26, 153–159 (2002). https://doi.org/10.1023/A:1016511611435

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016511611435

Search

Navigation